Biotech firm Humacyte Inc.
Author: Michael
Biotech firm Humacyte Inc.
Health tech startup Ultrahuman has launched Ultra
NFX General Partner Omri Drory wonders why more
Preclinical data suggest Telomir’s oral drug m
RLS-1496 enters Phase 1 aiming to modulate GPX4
MIT and Recursion have released Boltz-2, a next-g
Huma, a New York-based global digital health comp
Acquisition expected to support strategic collab
Genomics co-founder explains why recent advances